Impurity Supplier in India
Impurities manufacture from India called Rxn chemicals , having largest export worldwide like USA, Canada,China,Europe, Middle east and Asian countries.
| Ketoprofen Impurity E | 59512-16-2 | C16H15NO2 | 253.3 |
| Ketoprofen Impurity F | C16H13NO | 235.29 | |
| Ketoprofen Impurity G | C10H9NO2 | 175.19 | |
| Ketoprofen Impurity H | C9H7NO2 | 161.16 | |
| Ketoprofen Impurity I | C15H11NO | 221.26 | |
| Ketoprofen Impurity J | C18H18O3 | 282.34 | |
| Ketoprofen Methyl Ester | C17H16O3 | 268.32 | |
| Ketoprofen Impurity D | 107257-20-5 | C17H16O3 | 268.32 |
| Ketoprofen Related Compound C | 68432-95-1 | C10H10O4 | 194.19 |
| Ketoprofen Lysinate | 57469-78-0 | C16H14O3. C6H14N2O2 | 254.29 146.19 |
| Ketoprofen Ethyl Ester | 60658-04-0 | C18H18O3 | 282.34 |
| Ketoprofen Sodium Salt | 57495-14-4 | C16H13O3 Na | 253.28 22.99 |
| R-Ketoprofen | 56105-81-8 | C16H14O3 | 254.29 |
| (S)-Ketoprofen Tromethamine Salt (Dexketoprofen Trometamol) | 156604-79-4 | C16H14O3. C4H11NO3 | 254.29 121.14 |
| Ketoprofen Related Compound D | 66067-44-5 | C15H12O2 | 224.26 |
| Ketoprofen-13C-D3 | C15H11O313CD3 | 258.3 | |
| Ketoprofen metabolite | C16H16O3 | 256.3 | |
| (S)-Ketoprofen | C16H14O3 | 254.29 | |
| rac-Ketoprofen acyl-beta-D-glucuronide (mixture of isomers) | 76690-94-3 | C22H22O9 | 430.42 |
| (S)-(+)-Ketoprofen-d3 Tromethamine Salt | C16H11O3D3.C4H11NO3 | 257.31 121.14 | |
| (S)-(+)-Ketoprofen-d3 | C16H11O3D3 | 257.31 | |
| 4-Hydroxy ketorolac | 111930-01-9 | C15H13NO4 | 271.28 |
| Ketorolac Impurity H | C16H15NO3 | 269.3 | |
| Ketorolac Impurity I | C14H13NO | 211.27 | |
| Ketorolac Impurity J | C17H17NO3 | 283.33 | |
| Ketorolac | 74103-06-3 | C15H13NO3 | 255.28 |
| Ketorolac-d5 | 74103-06-3(non-d) | C15H8NO3D5 | 260.31 |
| 1-Keto Ketorolac | 113502-52-6 | C14H11NO2 | 225.25 |
| Ketorolac Impurity A | 154476-25-2 | C14H13NO2 | 227.27 |
| Ketorolac Impurity C | 1026936-07-1 | C15H13NO3 | 255.28 |
| Ketorolac Impurity F | C15H13NO3 | 255.28 | |
| Ketorolac Impurity D | 1391053-45-4 | C16H15NO4 | 285.3 |
| Ketorolac Impurity G | C16H15NO4 | 285.3 | |
| Ketorolac Impurity E | C19H22N2O5 | 358.4 | |
| KF31327 | 220060-39-9 | C24H28N6OS | 448.59 |
| Kynurenic-d5 Acid | C10H2NO3D5 | 194.2 | |
| Ketotifen Fumarate | C19H19NOS.C4H4O4 | 309.43 116.07 | |
| Ketotifen Impurity A | C19H19NS | 293.43 | |
| Ketotifen Impurity B | C20H23NO2S | 341.48 | |
| Ketotifen Impurity C | C19H21NO2S | 327.45 | |
| Ketotifen Impurity D | 88456-70-6 | C19H19NO2S | 325.43 |
| Ketotifen Impurity E | C19H19NOS | 309.43 | |
| Ketotifen Impurity F | C19H19NOS | 309.43 | |
| Ketotifen Impurity G | C19H17NO2S | 323.42 | |
| Kojic Acid | C6H6O4 | 142.11 | |
| Ketanserin | 74050-98-9 | C22H22FN3O3 | 395.44 |
| Lamotrigine-13C3 | 84057-84-1(non-d) | C613C3H7Cl2N5 | 259.07 |
| Lamotrigine Dimer Impurity 2 | C19H14Cl4N10 | 524.2 | |
| Lamotrigine-13C-d3 | C9H4Cl2N5D3 | 260.1 | |
| Lamotrigine Impurity D | 661463-79-2 | C9H5Cl2N3O2 | 258.07 |
| Lamotrigine Related Compound C | C9H6Cl2N4O | 257.08 | |
| Lamotrigine Related Compound D | C16H9Cl4N5O | 429.1 | |
| Lamotrigine Impurity C | 94213-23-7 | C9H7Cl2N5 | 256.1 |
| Lamotrigine Impurity | N/A | C8H3Cl2NO | 200.03 |
| Lamotrigine Impurity E (2,3-Dichlorobenzoic Acid) | 50-45-3 | C7H4Cl2O2 | 191.01 |
| Lamotrigine Dimer Impurity 1 | C19H14Cl4N10 | 524.2 | |
| Lacidipine-d9 | 103890-78-4 | C26H24NO6D9 | 464.61 |
| Lacidipine | 103890-78-4 | C26H33NO6 | 455.56 |
| Lacidipine-d10 | 103890-78-4(non-d) | C26H23NO6D10 | 465.62 |
| Dehydro lacidipine | C26H31NO6 | 453.54 | |
| cis-Lacidipine | 103890-79-5 | C26H33NO6 | 455.55 |
| Lansoprazole | 103577-45-3 | C16H14F3N3O2S | 369.37 |
| Lansoprazole EP Impurity C | 103577-40-8 | C16H14F3N3OS | 353.37 |
| Lansoprazole EP Impurity D | 615-16-7 | C7H6N2O | 134.14 |
| Lansoprazole EP Impurity E | 583-39-1 | C7H6N2S | 150.2 |
| Lansoprazole EP Impurity F | 168167-42-8 | C14H12ClN3OS | 305.79 |
| Lansoprazole Sulfone N-Oxide | C16H14F3N3O4S | 401.37 | |
| 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine | C9H9ClF3NO | 239.63 | |
| Lansoprazole Impurity H | 1346598-28-4 | C23H16F3N5OS | 467.48 |
| Lansoprazole Impurity I | N/A | C23H16F3N5OS | 467.48 |
| Lansoprazole N-Trifuoroethyl Impurity | 1187926-84-6 | C18H15F6N3O2S | 451.39 |
| Lansoprazole EP Impurity B (Lansoprazole Sulfone) | 131926-99-3 | C16H14F3N3O3S | 385.37 |
| Lansoprazole N-(3-Methyl-4-Trifuoroethoxyl-Pyridin-2-yl) Impurity | N/A | C25H22F6N4O3S | 572.53 |
| (R)-Lansoprazole-d4 | 1246819-33-9 | C16H12F3N3O2SD4 | 375.41 |
| Lansoprazole Thioxo Impurity | 1246819-06-6 | C14H9N3OS | 267.31 |
| Lansoprazole Related Compound 1 | C14H13N3OS | 271.34 | |
| Lansoprazole Related Compound 2 (Des(trifluoroethyl) Lansoprazole Sulfide) | 131926-97-1 | C14H13N3OS | 271.34 |
| Lansoprazole Related Compound 3 | 1083100-27-9 | C25H22F6N4O2S | 556.53 |
| 5-Hydroxy Lansoprazole | 131926-98-2 | C16H14F3N3O3S | 385.37 |
| Lansoprazole-d4 | 103577-45-3(non-d) | C16H10F3N3O2SD4 | 373.39 |
| 5-Hydroxy Lansoprazole Sulfide | C16H14F3N3O2S | 369.37 | |
| 6-Hydroxy Lansoprazole Sulfide | C16H14F3N3O2S | 369.37 | |
| (R)-(+)-Lansoprazole | C16H14F3N3O2S | 369.37 | |
| Lansoprazole Glucuronide | N/A | C22H22F3N3O8S | 545.5 |
| Lansoprazole EP Impurity A | 213476-12-1 | C16H14F3N3O3S | 385.37 |
| Leflunomide | 75706-12-6 | C12H9F3N2O2 | 270.21 |
| Leflunomide Impurity F | C12H9F3N2O2 | 270.21 | |
| Leflunomide Impurity G | C12H12N2O2 | 216.24 | |
| Leflunomide Impurity H | 24522-30-3 | C10H7F3N2O | 228.18 |
| Leflunomide-d4 | 75706-12-6 (non-d) | C12H5F3N2O2D4 | 274.24 |
| 2-Cyano-3OH-N-(4-trifluoromethylphenyl) crotonamide | 163451-81-8 | C12H9F3N2O2 | 270.21 |
| 2-Cyano-3OH-N-(4-trifluoromethylphenyl) crotonamide-d4 | 108605-62-5 | C12H5F3N2O2D4 | 274.24 |
| Leflunomide Impurity E | C12H9F3N2O2 | 270.21 | |
| Leflunomide Impurity B | 163451-81-8 | C12H9F3N2O2 | 270.21 |
| Leflunomide Impurity C | 61643-23-0 | C12H9F3N2O2 | 270.21 |
| Leflunomide Impurity A | 455-14-1 | C7H6F3N | 161.13 |
| Leflunomide Impurity D | 42831-50-5 | C5H5NO3 | 127.1 |
| Levetiracetam | 102767-28-2 | C8H14N2O2 | 170.21 |
| Levetiracetam-d6 | 102767-28-2(non-d) | C8H8D6N2O2 | 176.25 |
| Levetiracetam Metabolite | 102849-49-0 | C8H13NO3 | 171.2 |
| Levetiracetam Impurity B | 358629-47-7 | C8H12N2O2 | 168.2 |
| Levetiracetam Impurity C | 72762-00-6 | C5H5NO | 95.1 |
| Levetiracetam Impurity D | 103765-01-1 | C8H14N2O2 | 170.21 |
| Levetiracetam Imurity (L-2-Aminobutanamide HCl,S-2-Aminobutanamide HCl) | C4H10N2O.HCl | 102.14 36.46 | |
| Levetiracetam Impurity 3 | N/A | C8H15ClN2O2 | 206.67 |
| Levetiracetam Impurity A | 67118-31-4 | C8H13NO3 | 171.2 |
| Lidocaine-d6 HCl | 1215823-29-2 (free base)) | C14H16N2OD6. HCl | 240.38 36.46 |
| Lidocaine Impurity F | C14H22N2O . HCl | 234.34 36.46 | |
| Lidocaine Impurity G | C13H20N2O . HCl | 220.32 36.46 | |
| Lidocaine Impurity K | 50295-20-0 | C13H20N2O. HCl | 220.32 36.46 |
| 3'-Hydroxy Lidocaine | 34604-55-2 | C14H22N2O2 | 250.34 |
| Lidocaine Impurity A | C8H11N | 121.18 | |
| Lidocaine Impurity C | 2198-53-0 | C10H13NO | 163.22 |
| Lidocaine Impurity H | C10H12ClNO | 197.67 | |
| Lidocaine Impurity I | C14H22N2O | 234.34 | |
| Monoethylglycinexylidine HCl (Impurity D) | 7729-94-4 | C12H18N2O.HCl | 206.29 36.46 |
| Lidocaine Impurity J | N/A | C14H22N2O | 234.34 |
| Lidocaine Impurity 1 (2-(Diethylamino)-N-(Diethylaminoyl)acetamide) | N/A | C11H23N3O2 | 229.32 |
| Lidocaine Impurity 2 (2-[(Diethylcarbamoyl)amino]-N, N-Diethylacetamide) | N/A | C11H23N3O2 | 229.32 |
| Lidocaine Impurity 3 | C14H19N3 | 229.33 | |
| Lidocaine | 137-58-6 | C14H22N2O | 234.34 |
| Lidocaine Dichloro Impurity | 39084-88-3 | C10H11Cl2NO | 232.11 |
| Monoethyl Glycinexylidine-d6 HCl | 1216698-89-3 (free base) | C12H12N2OD6. HCl | 212.33 36.46 |
| Glycinexylidide HCl | 18865-38-8 | C10H14N2O.HCl | 178.24 36.46 |
| Glycinexylidide-d6 | 18865-38-8(non-d) | C10H8N2OD6 | 184.27 |
| Lidocaine-d10 | 137-58-6 (non-d) | C14H12N2OD10 | 244.4 |
| 2,6-Xylidine-d6 HCl | C8H5ND6. HCl | 127.22 36.46 | |
| Lidocaine Impurity B (Lidocaine N-Oxide) | 2903-45-9 | C14H22N2O2 | 250.34 |
| Lidocaine Impurity E | 745798-07-6 | C20H25N3O2 | 339.44 |
| Linezolid-d3 | 1127120-38-0 | C16H17FN3O4D3 | 340.37 |
| Thio Linezolid (Linezolid Related Compound B) | N/A | C16H20FN3O3S | 353.42 |
| Linezolid Related Compound A | 168828-84-0 | C14H16FN5O3 | 321.31 |
| Linezolid Related Compound C | 168828-90-8 | C14H18FN3O3 | 295.32 |
| Defluoro Linezolid | 556801-15-1 | C16H21N3O4 | 319.36 |
| Linezolid Impurity D HCl | 1391068-25-9 | C15H22FN3O3. HCl | 311.36 36.46 |
| Linezolid Dimer | 908143-04-4 | C30H35F2N5O7 | 615.64 |
| R-Linezolid-d3 | 1127120-38-0 | C16H17FN3O4D3 | 340.37 |
| Linezolid Impurity (N,O-Desethylene Linezolid) | 1219708-30-1 | C14H18FN3O4 | 311.32 |
| Linezolid impurity PNU177636 | C20H26FN3O5 | 407.45 | |
| Linezolid Related Compound (Linezolid N-Oxide) | 189038-36-6 | C16H20FN3O5 | 353.35 |
| Linezolid-13C-d3 | 165800-03-3 | C1513CH17D3FN3O4 | 341.36 |
| Linezolid related Compound | 174649-09-3 | C15H19FN2O6S | 374.39 |
| Linezolid Related Impurity 1 | 1532560-87-4 | C13H20FN3O2 | 269.32 |
| Linezolid Impurity 7 HCl | 333753-71-2 (free base) | C15H22FN3O3. HCl | 311.36 36.46 |
| Racemic-Linezolid Impurity PNU140155 | C15H22FN3O3 | 311.36 | |
| Linezolid Related Impurity 2 HCl | C15H22FN3O3. HCl | 311.36 36.46 | |
| Linezolid | 165800-03-3 | C16H20FN3O4 | 337.35 |
| Linezolid-13C2-d3 | C16H17FN3O4D3 | 342.35 | |
| Benzyl 3-Fluoro-4-(4-morpholinyl)phenyl)carbamate | 168828-81-7 | C18H19FN2O3 | 330.36 |
| Linezolid Impurity ((5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-hydroxymethyl-2-oxazolidinone) | 168828-82-8 | C14H17FN2O4 | 296.3 |
| R-Linezolid | 872992-20-6 | C16H20FN3O4 | 337.35 |
| Linezolid Impurity PNU140155 | C15H22FN3O3 | 311.36 | |
| Lisinopril-d5 | 83915-83-7 | C21H26N3O5D5 | 410.53 |
| Lisinopril Impurity C ((S, S, S)-Diketopiperazine) | 328385-86-0 | C21H29N3O4 | 387.48 |
| Lisinopril | C21H31N3O5 | 405.5 | |
| Lisinopril Impurity A | NA | C10H13NO2 | 179.22 |
| Lisinopril Impurity D | NA | C21H29N3O4 | 387.48 |
| Lisinopril Impurity E | 85955-59-5 | C21H31N3O5 | 405.5 |
| Lisinopril Impurity F | NA | C21H37N3O5 | 411.55 |
| Lisinopril CPP Lysine Impurity | 138247-43-5 | C16H24N2O4 | 308.38 |
| Lisinopril Impurity H (Dimer Impurity) | N/A | C37H53N5O8 | 695.86 |
| Loxapine | 54810-23-0 | C18H18ClN3O | 327.82 |
| Loxapine-d8 | 54810-23-0(non-d) | C18H10ClN3OD8 | 335.86 |
| Loxapine N+-Glucuronide | C24H27ClN3O7 | 504.95 | |
| Loxapine N-Oxide | 25967-34-4 | C18H18ClN3O2 | 343.82 |
| 7-Hydroxy-Loxapine | N/A | C18H18ClN3O2 | 343.82 |
| 7-Hydroxy-Loxapine-d8 | N/A | C18H10ClN3O2D8 | 351.86 |
| 7-Hydroxy-Loxapine N-Oxide | N/A | C18H18ClN3O3 | 359.82 |
| 7-Hydroxy-Loxapine Sulfate | N/A | C18H18ClN3O5S | 423.88 |
| 7-Hydroxy-Loxapine-O-Glucuronide | N/A | C24H26ClN3O8 | 519.94 |
| 8-Hydroxy Loxapine | 61443-77-4 | C18H18ClN3O2 | 343.82 |
| 8-Hydroxy-Loxapine-d8 | N/A | C18H10ClN3O2D8 | 351.86 |
| 8-Hydroxy-Loxapine N-Oxide | N/A | C18H18ClN3O3 | 359.82 |
| 8-Hydroxy-Loxapine Sulfate | N/A | C18H18ClN3O5S | 423.88 |
| 8-Hydroxy-Loxapine-O-Glucuronide | N/A | C24H26ClN3O8 | 519.94 |
| Lurasidone Hydrochloride | 367514-88-3 | C28H36N4O2S | 492.69 |
| Lurasidone-d8 | C28H28N4O2SD8 | 500.74 | |
| Lurasidone Inactive Metabolite 14283 | C28H36N4O3S | 508.69 | |
| Lurasidone Inactive Metabolite 14326 | C28H36N4O3S | 508.69 | |
| Lurasidone Inactive Metabolite 14283-d8 | N/A | C28H28N4O3SD8 | 516.74 |
| Lurasidone Inactive Metabolite 14326-d8 | N/A | C28H28N4O3SD8 | 516.74 |
| Lurasidone Sulfoxide | C28H36N4O3S | 508.69 | |
| Loperamide HCl | 34552-83-5 | C29H33ClN2O2.HCl | 513.51 |
| Lapachol | 84-79-7 | C15H14O3 | 242.28 |
| Desmethyl Loperamide | 66164-07-6 | C28H31ClN2O2 | 463.02 |
| 2̢۪-O-Methyl Lactose | 77667-98-2 | C13H24O11 | 356.33 |
| Loperamide-d6 HCl | 34552-83-5 (non-d) | C29H27ClN2O2D6 | 483.09 |
| Lincomycin B HCl | 11021-35-5 | C17H32N2O6S HCl | 392.52 36.46 |
| epi-Lincomycin-2,7-dipalmitate | C51H95NO8S | 882.39 | |
| Lincomycin-2,7-dipalmitate | C51H95NO8S | 882.39 | |
| Lincomycin impurity A | C18H34N2O6S | 406.55 | |
| Lincomycin impurity C | C17H32N2O6S | 392.52 | |
| Lincomycin 2,4-Phosphate | N/A | C18H33N2O8PS | 468.51 |
| 7-epi Lincomycin | 26389-84-4 | C18H34N2O6S | 406.55 |
| Loperamide N-Oxide | NULL | C29H33ClN2O3 | 493.05 |
| Lumiflavin | 1088-56-8 | C13H12N4O2 | 256.27 |
| Loperamide Impurity A | N/A | C35H37ClN2O2 | 553.15 |
| Lorcaserin HCl Hemihydrate | 856681-05-5 | C11H14ClN. HCl. 0.5 H2O | 195.69 36.46 0.5 18.02 |
| Lorcaserin-D4 | C11H10ClND4 | 199.72 | |
| Lorcaserin impurity A | C11H14ClN | 195.69 | |
| Lorcaserin impurity B | 953789-37-2 | C11H15Cl2N . HCl | 232.15 36.46 |
| Lorcaserin impurity C | C13H16ClNO | 237.73 | |
| Lorcaserin impurity D | 1030624-36-2 | C11H14ClNO2 | 227.69 |
| Lorcaserin impurity E | C11H14ClN . C4H6O6 | 195.69 150.09 | |
| Lorcaserin Dechloro Impurity | N/A | C11H15N | 161.25 |
| Lorcaserin N-Oxide Impurity | N/A | C11H14ClNO | 211.69 |
| Lorcaserin Lactam Impurity | N/A | C11H12ClNO | 209.68 |
| Lorcaserin 5-Methyl Isomer | N/A | C11H14ClN | 195.69 |
| Lactitol Impurity B | N/A | C12H24O11 | 344.32 |
| Loratadine (Desloratadine Impurity E) | 79794-75-5 | C22H23ClN2O2 | 382.89 |
| 3-Hydroxy Desloratadine Pyridine N-oxide | NULL | C19H19ClN2O2 | 342.83 |
| 3-Hydroxy desloratadine-d4 | C19H15ClN2OD4 | 330.85 | |
| 5-Hydroxy desloratadine | 117811-12-8 | C19H19ClN2O | 326.83 |
| 6-Hydroxy Desloratadine | 119410-05-8 | C19H19ClN2O | 326.83 |
| 3-Hydroxy Desloratadine | C19H19ClN2O | 326.83 | |
| Desloratadine Pyridine N-Oxide | 169253-26-3 | C19H19ClN2O | 326.83 |
| Desloratadine Impurity 1 | C19H19ClN2 | 310.83 | |
| Desloratadine Impurity 2 | 117811-13-9 | C19H19ClN2 | 310.83 |
| Desloratadine Impurity 3 | C19H19ClN2 | 310.83 | |
| Desloratadine Impurity 4 | C20H21ClN2 | 324.86 | |
| Loratadine EP Impurity D (Desloratadine) | 100643-71-8 | C19H19ClN2 | 310.83 |
| Desloratadine Impurity 5 | 38092-88-5 | C20H21ClN2 | 324.86 |
| Desloratadine Impurity 6 | 38092-90-9 | C20H21ClN2 | 324.86 |
| Loratadine EP Impurity B | 31251-41-9 | C14H10ClNO | 243.69 |
| Loratadine Impurity D | 38089-93-9 | C20H23ClN2O | 342.87 |
| Loratadine Impurity E | 133330-60-6 | C14H9Cl2NO | 278.14 |
| Loratadine EP Impurity A | 133284-74-9 | C22H25ClN2O3 | 400.91 |
| Loratadine EP Impurity C | 165739-83-3 | C22H22Cl2N2O2 | 417.34 |
| N-Formyl Desloratadine (Desloratadine Impurity D) | C20H19ClN2O | 338.84 | |
| Loratadine EP Impurity G (Methyl Loratadine) | 38092-89-6 | C20H21ClN2 | 324.86 |
| Iso Desloratadine HCl | 183198-49-4 (free base) | C19H19ClN2. HCl | 310.83 36.46 |
| Loratadine-d5 | 1020719-57-6 | C22H18D5ClN2O2 | 387.92 |
| Desloratadine N-Hydroxypiperidine | 1193725-73-3 | C19H19ClN2O | 326.83 |
| Desloratadine Impurity Disodium Salt | N/A | C25H23ClN2O6. 2 Na | 482.92 2 22.99 |
| Desloratadine Impurity A | 38092-95-4 | C19H20N2 | 276.38 |
| Desloratadine Impurity B | 117796-50-6 | C19H19BrN2 | 355.28 |
| Desloratadine Impurity C | 117811-20-8 | C19H17ClN2 | 308.81 |
| 4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid | 107256-32-6 | C20H21ClN2O3 | 372.85 |
| 11-Fluoro Desloratadine | 298220-99-2 | C19H20ClFN2 | 330.84 |
| Descarboethoxy loratadine-d5 | 79794-75-5(non-d) | C19H14D5ClN2.HCl | 315.86 |
| N-Acetyldesloratadine | 117796-52-8 | C21H21ClN2O | 352.87 |
| Loratadine EP Impurity F | 125743-80-8 | C22H24ClFN2O2 | 402.9 |
| 12-Hydroxy Loratadine | C22H25ClN2O3 | 400.91 | |
| 3-Hydroxy desloratadine HCl | 19410-08-1 | C19H19ClN2O.HCl | 326.83 36.46 |
| 4-Hydroxymethyl loratadine | 609806-40-8 | C23H2ClN2O3 | 412.91 |
| 3-Hydroxy desloratadine glucuronide | 774538-89-5 | C25H27ClN2O7 | 502.96 |
| 2-Hydroxymethyl loratadine | 609806-39-5 | C23H2ClN2O3 | 412.91 |
| Losartan potassium salt | 124750-99-8 | C22H22ClKN6O | 461.01 |
| Losartan Impurity J | 1006062-27-6 | C24H25ClN6O2 | 464.96 |
| Losartan Impurity K | 1159977-26-0 | C21H20Cl2N6 | 427.34 |
| Losartan N1-Glucuronide | C28H31ClN6O7 | 599.05 | |
| Losartan Carboxylic Acid Acyl-Beta-D-Glucuronide | N/A | C29H31ClN6O7 | 611.06 |
| Losartan Related Compound A | 1247750-67-0 | C22H20ClN3O | 377.88 |
| Losartan Related Compound B | N/A | C22H22ClN3O | 379.89 |
| Losartan Impurity C (Isolosartan) | 114799-13-2 | C22H23ClN6O | 422.92 |
| Losartan Impurity (5-(4'-Methylbiphenyl-2-yl)-1-Trityl-1H-Tetrazole) | 124750-53-4 | C33H26N4 | 478.6 |
| N-Trithyl Losartan | 124751-00-4 | C41H37ClN6O | 665.24 |
| Losartan Carboxylic Acid | 124750-92-1 | C22H21ClN6O2 | 436.9 |
| Losartan Impurity B | 1159977-48-6 | C44H44Cl2N12O2 | 843.83 |
| Losartan Carboxaldehyde | 114798-36-6 | C22H21ClN6O | 420.91 |
| Losartan Trityl Ether (Impurity I) | 1006062-28-7 | C41H37ClN6O | 665.24 |
| Losartan Impurity D | C8H11ClN2O | 186.64 | |
| Losartan Impurity E | C14H12N4 | 236.28 | |
| Losartan Impurity F | C25H29ClN6O | 465 | |
| Losartan-d4 | 124750-99-8(non-d) | C22H19D4ClN6O | 425.94 |
| Losartan Carboxylic Acid-d4 | 1246820-62-1 | C22H17ClN6O2D4 | 440.93 |
| Losartan N2-glucuronide | C28H31ClN6O7 | 599.05 | |
| Losartan Potassium Impurity L | 230971-71-8 | C44H44Cl2N12O | 827.83 |
| Losartan Potassium Impurity M | 230971-72-9 | C44H44Cl2N12O | 827.83 |
| Losartan Impurity G | 165276-38-0 | C22H21ClN6 | 404.91 |
| Lovastatin hydroxy acid sodium salt | 75225-51-3 | C24H37O6.Na | 444.55 |
| Lovastatin Impurity F | C24H34O5 | 402.54 | |
| Lovastatin 6'-Exomethylene Impurity | C24H34O5 | 402.54 | |
| Lovastatin 6'-beta-Hydroxy Impurity | C24H36O6 | 420.55 | |
| Des(2-methylbutyrate) lovastatin hydroxy acid sodium salt | 75225-51-3 | C19H29O5.Na | 360.43 |
| Lovastatin-d3 Hydroxy Acid Sodium Salt | 1279029-75-2 | C24H34O6D3.Na | 424.58 22.99 |
| Lovastatin-d9 | NULL | C24H27O5D9 | 413.61 |
| Lovastatin-d9 hydroxy acid sodium salt | NULL | C24H28O6D9.Na | 430.61 22.99 |
| Lovastatin-d3 | 1002345-93-8 | C24H33O5D3 | 407.5 |
| Lovastatin | C24H36O5 | 404.55 | |
| Hydroxy Lovastatin | N/A | C24H36O7 | 436.55 |
| Lovastatin Dimer | C48H72O10 | 809.1 | |
| Levocetirizine-d4 | 130018-77-8 | C21H21ClN2O3D4 | 392.92 |
| N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide | 1391053-09-0 | C13H20N2O3 | 252.32 |
| Levocetirizine Impurity 1 | C28H32ClN3O2 | 478.04 | |
| 4-Chlorobenzhydrylimine | NA | C13H10ClN | 215.68 |
| 2-Chlorobenzhydryl amine | 5267-39-0 | C13H12ClN | 217.7 |
| N-Benzyl-2-chloro-N(chloroacetyl)acetamide | NA | C11H11Cl2NO2 | 260.12 |
| [2-[4-[4-chlorophenylmethyl]-1-piperazinyl]-ethoxy]acetamide | NA | C15H22ClN3O2 | 311.81 |
| 1-Benzylaziridin-2-one | NA | C9H9NO | 147.18 |
| 2-(p-Chlorobenzhydryl piperazine)-[(N,N'-bis(2-ethoxy acetic acid)] | NA | C25H32ClN2O6 | 492 |
| Levocetetrizine N-Oxide | NA | C21H25ClN2O4 | 404.9 |
| levocetirizine Impurity | C17H19ClN2 | 286.81 | |
| Linuron-d6 | 330-55-2 (non-d) | C9H4Cl2N2O2D6 | 255.13 |
| Letrozole-d4 | 1133712-96-5 | C17H7N5D4 | 289.33 |
| Carbinol Metabolite of Letrozole | 134521-16-7 | C15H10N2O | 234.26 |
| Letrozole | 112809-51-5 | C17H11N5 | 285.31 |
| Letrozole Related Compound A | 112809-52-6 | C17H11N5 | 285.31 |
| Letrozole Impurity B | 113402-31-6 | C22H13N3 | 319.39 |
| Letrozole Impurity C | 112809-25-3 | C10H8N4 | 184.2 |
| R-Lercanidipine | NULL | C36H41N3O6 | 611.74 |
| Lercanidipine Impurity A | C19H22N2O6 | 374.4 | |
| Lercanidipine Impurity | C21H26N2O6 | 402.45 | |
| Lercanidipine Dimethyl Ester Impurity | N/A | C17H18N2O6 | 346.34 |
| Lercanidipine Ethyl Methyl Ester Impurity (Impurity 5) | 39562-70-4 | C18H20N2O6 | 360.37 |
| Lercanidipine Ethyl Impurity (Impurity 4) | N/A | C37H43N3O6 | 625.77 |
| Lercanidipine Impurity 6 | C36H41N3O6 | 611.74 | |
| R-Lercanidipine-d3 | NULL | C36H38D3N3O6 | 614.74 |
| S-Lercanidipine | NULL | C36H41N3O6 | 611.74 |
| S-Lercanidipine-d3 | NULL | C36H38N3O6 | 614.74 |
| Lercanidipine Impurity D HCl (Dehydro Lercanidipine HCl) | 887769-34-8 (free base) | C36H39N3O6.HCl | 609.73 36.46 |
| Lercanidipine HCl | 132866-11-6 | C36H41N3O6.HCl | 611.74 36.46 |
| Lercanidipine Impurity B | 1119226-97-9 | C35H37N3O6 | 595.7 |
| Lercanidipine-13C-d3 HCl | C35H38N3O613CD3. HCl | 615.75 36.46 | |
| Lercanidipine Impurity C | C38H45N3O6 | 639.8 | |
| Lithocholic-2,2,3,4,4-d5 Acid | 434-13-9 (non-d) | C24H35O3D5 | 381.61 |
| Lithocholic-2,2,4,4-d4 Acid | 434-13-9 (non-d) | C24H36O3D4 | 380.61 |
| Taurolithocholic-2,2,3,4,4-D5 Acid | C26H40NO5SD5 | 488.75 | |
| Taurolithocholic-2,2,4,4-D4 Acid | C26H41NO5SD4 | 487.75 | |
| Lasofoxifene | 180916-16-9 | C28H31NO2 | 413.56 |
| Lasofoxifene-d4 | 180916-16-9 (non-d) | C28H27NO2D4 | 417.59 |
| Lasofoxifene glucuronide | C34H39NO8 | 589.69 | |
| rac-Lasofoxifene-d5 | C28H26NO2D5 | 418.59 | |
| Lamivudine-13C-d2 | 134678-17-4 | C8H9N3O3SD2 | 232.26 |
| Lamivudine-13C-15N2 | C8H11N3O3S | 232.23 | |
| Lamivudine | 134678-17-4 | C8H11N3O3S | 229.26 |
| Lamivudine Impurity B | C8H11N3O3S | 229.26 | |
| Lamivudine acid | C8H9N3O4S | 243.24 | |
| 5'-Epi Lamivudine | 139757-68-9 | C8H11N3O3S | 229.26 |
| Lamivudine S-oxide | C8H11N3O4S | 245.26 | |
| Lubiprostone | 333963-40-9 | C20H32F2O5 | 390.47 |
| Lubiprostone-d4 | 333963-40-9 (non-d) | C20H28F2O5D4 | 394.5 |
| 15-Hydroxy lubiprostone-mixture of isomers | C20H34F2O5 | 392.49 | |
| 15-Hydroxy lubiprostone-d4 | C20H30F2O5D4 | 396.51 | |
| Lubiprostone | 136790-76-6 | C20H32F2O5 | 390.47 |
| Lubiprostone-d7 | 333963-40-9 (non-d) | C20H25F2O5D7 | 397.51 |
| Lubiprostone related compound 1 | C20H32F2O5 | 390.47 | |
| Lubiprostone related compound 2 | C20H32F2O5 | 390.47 | |
| Levonorgestrel Sulfate Sodium Salt | C21H27O5S.Na | 391.51 22.99 | |
| Levonorgestrel Impurity P | 100021-05-4 | C21H28O2 | 312.46 |
| Levonorgestrel Impurity C | C23H28O | 320.48 | |
| Levonorgestrel Impurity M | 51087-61-7 | C21H26O2 | 310.44 |
| Aromatic levonorgestrel | C22H28O2 | 324.47 | |
| Delta1 (10)-4, 5-dihydro-levonorgestrel | C21H28O2 | 312.46 | |
| Levonorgestrel Impurity A | 110785-09-6 | C21H26O2 | 310.44 |
| Levonorgestrel Impurity S | N/A | C22H30O2 | 326.48 |
| Levonorgestrel Impurity O | C22H32O3 | 344.5 | |
| Levonorgestrel Impurity L (18-Methylester-4-ene-3,17-dione) | 21800-83-9 | C19H26O2 | 286.42 |
| Levonorgestrel Impurity B | C21H28O2 | 312.46 | |
| Levonorgestrel-d6 ((-)-Norgestrel-d6) | 793-67-7 (non-d) | C21H22O2D6 | 318.49 |
| 10-alpha-Hydroxy Levonorgestrel | C21H28O3 | 328.46 | |
| Levonorgestrel Impurity V | C22H28O2 | 324.47 | |
| Levonorgestrel Impurity W | C21H24O2 | 308.42 | |
| Levonorgestrel Impurity R | 2322-77-2 | C20H28O2 | 300.44 |
| Levonorgestrel Impurity Q | 1038-28-4 | C20H30O2 | 302.46 |
| Levonorgestrel Impurity T | 799-43-9 | C22H30O2 | 326.48 |
| Delta-5(10)-8-alfa-Levonorgestrel | N/A | C21H28O2 | 312.46 |
| Levonorgestrel Impurity J (6-Keto Levonorgestrel) | 1175109-63-3 | C21H26O3 | 326.44 |
| Levonorgestrel Impurity D | 32419-58-2 | C21H30O | 298.47 |
| D-(-)-Norgestrel (Levonorgestrel) | 797-63-7 | C21H28O2 | 312.46 |
| 10-beta-Hydroxy Levonorgestrel | 21508-50-9 | C21H28O3 | 328.46 |
| 6-alfa-Hydroxy Levonorgestrel | C21H28O3 | 328.46 | |
| Levonorgestrel Impurity H (6-beta-Hydroxy Levonorgestrel) | C21H28O3 | 328.46 | |
| Levonorgestrel Impurity N | 4222-96-2 | C19H26O2 | 286.42 |
| Levofloxacin | C18H20FN3O4 | 361.38 | |
| Levofloxacin Related Compound C | C20H24FN3O4 | 389.43 | |
| Levofloxacin-d8 | 1217716-71-6 | C18H12FN3O4D8 | 369.42 |
| Levofloxacin Diformyl Impurity | 151377-74-1 | C18H18FN3O6 | 391.36 |
| Levofloxacin N-oxide | 117678-38-3 | C18H20FN3O5 | 377.38 |
| Levofloxacin-Acyl-D-Glucuronide | 160962-46-9 | C24H28FN3O10 | 537.5 |
| 9-Piperazine Levofloxacin Impurity | 178912-62-4 | C18H20FN3O4 | 361.38 |
| Descarboxyl Levofloxacin | 178964-53-9 | C17H20FN3O2 | 317.37 |
| Levofloxacin Tetrafluoro Impurity 1 | 110548-02-2 | C15H15F4NO4 | 349.28 |
| Levofloxacin Tetrafluoro Impurity 2 | 103995-33-1 | C14H12F4O4 | 320.24 |
| Levofloxacin Related Compound B | C13H9F2NO4 | 281.22 | |
| N-Desmethyl Levofloxacin (Levofloxacin Related Compound A) | C18H20FN3O4 | 347.35 | |
| N-Desmethyl Levofloxacin-d8 | C17H10FN3O4D8 | 1071-083A1 | |
| Levofloxacin-13C-d3 | C17H17FN3O413CD3 | 365.38 | |
| Defluoro Levofloxacin | 117620-85-6 | C18H21N3O4 | 343.39 |
| N,N̢۪-Desethylene Levofloxacin | C16H19N3O4 | 317.35 | |
| Levofloxacin Diamine | C15H16FN3O4 | 321.31 | |
| (R)-Levofloxacin | C18H20FN3O4 | 361.38 | |
| Lomerizine diHCl | C27H30F2N2O3.2 HCl | 468.55 2 36.46 | |
| Lomerizine-d8 diHCl | C27H22F2N2O3D8.2 HCl | 476.60 2 36.46 | |
| Lapatinib | 231277-92-2 | C29H26ClFN4O4S | 581.07 |
| Lapatinib Impurity 9 | N/A | C26H17ClFN3O3 | 473.9 |
| Lapatinib Impurity 10 | 1152131-73-1 | C26H17ClFN3O4 | 489.89 |
| Lapatinib 4-Fluoro Impurity | N/A | C29H26ClFN4O4S | 581.07 |
| Lapatinib 2-Fluoro Impurity | N/A | C29H26ClFN4O4S | 581.07 |
| Lapatinib Hydroxylamine | C29H26ClFN4O5S | 597.07 | |
| Lapatinib-d5 | C29H21ClFN4O4SD5 | 586.1 | |
| Lapatinib-d4 Ditosylate | 388082-78-8 (non-labelled) | C29H22ClFN4O4SD4 2C7H8O3S | 585.09 2 172.20 |
| O-De(3-fluorobenzyl) Lapatinib Ditosylate Salt | C22H21ClN4O4S . 2 C7H8O3S | 472.95 2 172.20 | |
| Lapatinib Ditosylate | 388082-77-7 | C29H26ClFN4O4S. 2 C7H8O3S | 581.07 2 172.20 |
| Lapatinib Impurity 1 | 1268997-70-1 | C22H21ClN4O4S | 472.95 |
| Lapatinib Impurity 2 | N/A | C29H24ClFN4O4S | 579.05 |
| Lapatinib Impurity 3 | N/A | C26H20ClFN4O2 | 474.93 |
| Lapatinib Impurity 8 | N/A | C26H19ClFN3O3 | 475.91 |
| Lenalidomide | 191732-72-6 | C13H13N3O3 | 259.27 |
| Lenalidomide-d5 | 191732-72-6 (non-d) | C13H8N3O3D5 | 264.35 |
| Lumiracoxib-acyl-β-D-glucuronide | C21H21Cl2NO8 | 486.31 | |
| Lumiracoxib | 220991-20-8 | C15H13ClFNO2 | 293.73 |
| Lacosamide | 175481-36-4 | C13H18N2O3 | 250.3 |
| LAC2-IBCA | C16H24N2O4 | 308.38 | |
| LAC2 NMBA Impurity | C14H20N2O3 | 264.33 | |
| (S)-Lacosamide | C13H18N2O3 | 250.3 | |
| (R)-O-Acetyl-Lacosamide | 1318777-54-6 | C14H18N2O4 | 278.31 |
| Lacosamide-d3 | 175481-36-4 (non-d) | C13H15N2O3D3 | 253.36 |
| Lacosamide-d3 | C13H15N2O3D3 | 253.32 | |
| N-Desacetyl Lacosamide HCl | C11H16N2O2.HCl | 208.26 36.46 | |
| Lacosamide-d6 | C13H12N2O3D6 | 256.34 | |
| Benzylamine | 100-46-9 | C7H9N | 107.16 |
| Desmethyl Lacosamide | 175481-38-6 | C12H16N2O3 | 236.27 |
| O-Acetyl Lacosamide | N/A | C14H18N2O4 | 278.31 |
| Desacetyl Desmethyl Lacosamide | N/A | C10H14N2O2 | 194.24 |
| Lumenfantrine | 82186-77-4 | C30H32Cl3NO | 528.95 |
| Lumenfantrine-d9 | 82186-77-4 (non-d) | C30H23Cl3NOD9 | 538.01 |
| Lumenfantrine glucuronide (mixture of diasteromers) | C36H40Cl3NO7 | 705.08 | |
| N-Desbutyl Lumefantrine | C26H24Cl3NO | 472.85 | |
| Lumenfantrine Impurity A | NA | C30H32Cl3NO | 528.95 |
| Keto Impurity | NA | C23H27Cl2NO2 | 420.38 |
| 2-(2,7-Dichloro-9H-fluoren-4-yl)oxirane | N/A | C15H10Cl2O | 277.15 |
| 2-(Dibutylamino)-1-(2,7-dichloro-9H-fluoren-4-yl)ethanol | N/A | C23H29Cl2NO | 406.4 |
| Lopinavir | C37H48N4O5 | 628.82 | |
| Lopinavir-d8 | C37H40N4O5D8 | 636.87 | |
| Lopinavir Impurity S | N/A | C47H58N4O7 | 791.01 |
| Lopinavir Impurity T | N/A | C57H66N4O7 | 919.18 |
| Lopinavir Metabolite M1 | 192725-39-6 | C37H46N4O6 | 642.8 |
| Lopinavir Metabolite M3-M4 | 357275-54-8 | C37H48N4O6 | 644.82 |
| Lopinavir Impurity R | C47H58N4O7 | 791.01 | |
| 4-Oxo Lopinavir | C37H46N4O5 | 626.8 | |
| 12-Hydroxy Lauric Acid-d20 | 505-95-3 (non-d) | C12H4O3D20 | 236.44 |
| 12-Hydroxy Lauric Acid | C12H24O3 | 216.32 | |
| Latanoprost | 130209-82-4 | C26H40O5 | 432.61 |
| 15-Keto Latanoprost Acid | C23H32O5 | 388.51 | |
| Latanoprost Impurity (Diphenylphosphine Isopropyl Ester) | N/A | C20H25O3P | 344.39 |
| 9-Acetyl Latanoprost | N/A | C28H42O6 | 474.64 |
| Tafluprost | 209860-87-7 | C25H34F2O5 | 452.54 |
| Tafluprost acid | 209860-88-8 | C22H28F2O5 | 410.46 |
| 15(S)-Latanoprost | 145773-22-4 | C26H40O5 | 432.61 |
| 5-trans-Latanoprost | C26H40O5 | 432.6 | |
| 15-Keto Latanoprost | C26H38O5 | 430.59 | |
| 5,6-trans-Latanoprost (50.0 mg in 5.0 ml methyl acetate) | C26H40O5 | 432.61 | |
| trans (15S)-Latanoprost | trans (15S)-Latanoprost | C26H40O5 | 432.61 |
| Latanoprost acid | 41639-83-2 | C23H34O5 | 390.52 |
| 15(R)-trans-Latanoprost (10.0 mg in 1.0 ml methyl acetate) | C26H40O5 | 432.61 | |
| Latanoprost Epoxide (mixture of isomers) | C26H40O6 | 448.61 | |
| Lupeol | C30H50O | 426.73 | |
| Levosulpiride | 23672-07-3 | C15H23N3O4S | 341.43 |
| Levosulpiride-d3 | C15H20D3N3O4S | 344.44 | |
| Lornoxicam | 70374-39-9 | C13H10ClN3O4S2 | 371.82 |
| Lornoxicam Impurity 9 | 70374-36-6 | C5H4ClNO4S2 | 241.67 |
| Lornoxicam Impurity 1 | C12H8ClN3O6S3 | 421.86 | |
| Lornoxicam Impurity 2 | C12H10ClN3O5S3 | 407.88 | |
| Lornoxicam Impurity 3 | N/A | C5H3ClO4S2 | 226.66 |
| Lornoxicam Impurity 4 | N/A | C9H12ClNO6S2 | 329.78 |
| Lornoxicam Impurity 5 | N/A | C9H13ClN2O5S2 | 328.8 |
| Lornoxicam Impurity 6 | C6H5ClO4S2 | 240.69 | |
| Lornoxicam Impurity 7 | C7H6N2O3 | 166.14 | |
| Lornoxicam Impurity 8 | 187746-94-7 | C5H3ClO5S2 | 242.66 |
| Luliconazole | 187164-19-8 | Luliconazole | 354.28 |
| (R)-(Z)-Luliconazole Isomer | C14H9Cl2N3S2 | 354.28 | |
| (S)-(E)-Luliconazole Isomer | 256424-63-2 | C14H9Cl2N3S2 | 354.28 |
| Luliconazole Z-Isomer | C14H9Cl2N3S2 | 354.28 | |
| Laropiprant | 571170-77-9 | C21H19ClFNO4S | 435.91 |
| Laropiprant-d4 | 1132664-22-2 | C21H15ClFNO4SD4 | 439.96 |
| R-Laropiprant | C21H19ClFNO4S | 435.91 | |
| S-Laropiprant | C21H19ClFNO4S | 435.91 | |
| Levomefolate-d4 | C20H21N7O6D4 | 463.49 | |
| Levomefolate | C20H25N7O6 | 459.47 | |
| L-382 | |||
| Levomefolate-d5 | C20H20N7O6D5 | 464.5 | |
| Levomefolate-13C-d3 | C20H22N7O6D3 | 463.47 | |
| Calcium Levomefolate (L-5-Methyltetrahydrofolate Calcium Salt.5H2O) | C20H23N7O6.Ca.5 H2O | 457.45 40.08 5 18.02 | |
| Loteprednol | 129260-79-3 | C21H27ClO5 | 394.9 |
| Loteprednol Etabonate | 82034-46-6 | C24H31ClO7 | 466.96 |
| Loteprednol Etabonate-d3 | C24H28ClO7D3 | 469.98 | |
| Loteprednol Etabonate-d5 | 82034-46-6 (non-labelled) | C24H26ClO7D5 | 471.99 |
| Leuprolide Acetate (Leuprorelin Acetate) | 74381-53-6 | C59H84N16O12.C2H4O2 | 1269.48 |
| Leuprolide-d5 | C59H79N16O12D5 | 1214.46 | |
| Levosimendan | 141505-33-1 | C14H12N6O | 280.29 |
| Levosimendan Impurity (2-[2-[4-(2-Azidotetrahydro-3-Methyl-5-oxo-2-Furanyl)phenyl]hydrazinylidene]propanedinitrile) | 252638-01-0 | C14H11N7O2 | 309.29 |
| Levosimendan Impurity 1 | C22H23N7O2 | 417.47 | |
| Levosimendan Impurity 2 | C16H17N5O3 | 327.35 | |
| Levosimendan Impurity 3 | C30H30N12O3 | 606.65 | |
| Linagliptin | 668270-12-0 | C25H28N8O2 | 472.55 |
| Linagliptin Impurity D | C20H18N6O3 | 390.4 | |
| Linagliptin Impurity F | C19H26N4O2 | 342.44 | |
| Linagliptin Impurity G | C36H40N10O4 | 676.78 | |
| Linagliptin Impurity N | C31H32N10O2 | 576.67 | |
| Linagliptin Impurity M | C15H20N4 | 256.35 | |
| Linagliptin Impurity S | C25H29BrN8O2 | 553.47 | |
| Linagliptin-d3 | N/A | C25H25N8O2D3 | 475.57 |
| Linagliptin Diene Impurity | N/A | C25H28N8O2 | 472.55 |
| Linagliptin Dimer Impurity | N/A | C52H59N17O4 | 986.16 |
| Linagliptin Dimer Impurity 2 | C50H56N16O4 | 945.11 | |
| Linagliptin Phthalimide Impurity | C33H32N8O4 | 604.67 | |
| Linagliptin Dimer Impurity 3 | C52H60N16O4 | 973.16 | |
| Linagliptin Metabolite CD1790 | C25H27N7O3 | 473.54 | |
| Linagliptin Impurity B | C26H21BrN8O2 | 557.41 | |
| Levomedetomidine HCl | 119717-21-4 | C13H17N2Cl | 236.75 |
| Levomedetomidine | C13H16N2 | 200.29 | |
| Levothyroxine-13C6 | C15H11I4NO4 | 782.81 | |
| Levothyroxine acyl glucuronide | C21H19I4NO10 | 953 | |
| Levothyroxine phenolic glucuronide | C21H19I4NO10 | 953 | |
| Levothyroxine sulfate | C15H11I4NO7S | 856.94 | |
| O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-hydroxy-l-tyrosine | C15H11I4NO5 | 792.88 | |
| 2-Hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid | C14H8I4O5 | 763.83 | |
| N-Formyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine | C16H11I4NO5 | 804.89 | |
| 2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetamide | C14H9I4NO3 | 746.85 | |
| N-Acetyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine | C17H13I4NO5 | 818.91 | |
| 2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid | C14H8I4O4 | 747.84 | |
| 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzaldehyde | C13H6I4O3 | 717.81 | |
| 4-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid | C13H6I4O4 | 733.81 | |
| O-(4-Hydroxy-3,5-Diiodophenyl)-3,5-Diiodo-beta-Hydroxy-L-Tyrosine | N/A | C15H11I4NO5 | 792,88 |
| (S)-2-Amino-3-[4-[4-(4-Hydroxy-3,5-Diiodophenoxy)-3,5-Diiodophenoxy]- 3,5-Diiodophenyl]propanoic Acid | N/A | C21H13I6NO5 | 1120.77 |
| Levothyroxine N-Methylamine | C16H14I4N2O3 | 789.92 | |
| Levothyroxine N-methylamide | C16H14I4N2O3 | 789.92 | |
| 3,5-Diiodo-L-tyrosine | C9H9I2NO3 | 432.99 | |
| Levothyroxine Related Compound (2-Acetamido-3-(4-acetoxy-3,5-diiodophenyl)propanoic Acid) | 153324-21-1 | C13H13I2NO5 | 517.06 |
| Levothyroxine Related Compound (N-Acetyl-3,5-Diiodo-L-Tyrosine) | 1027-28-7 | C11H11I2NO4 | 475.02 |
| Levothyroxine Related Compound (N-Acetyl 3,5-diiodo-L-tyrosine Methyl Ester) | 56460-41-4 | C12H13I2NO4 | 489.05 |
| Bis(p-anisyl)iodonium bromide | C14H14IO2.Br | 341.17 79.90 | |
| Levothyroxine Related Compound (2-Acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) Propanoic Acid) | 886203-79-8 | C18H17I2NO5 | 581.15 |
| 2-Amino-3(3-bromo-4-(4-hydroxyphenoxy)-5-iodophenyl)propanoic acid | C15H13BrINO4 | 478.08 | |
| Levothyroxine Related Compound (2-Amino-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl)propanoic acid) | 94345-95-6 | C16H15I2NO4 | 539.11 |
| Levothyroxine Related Compound (Methyl 2-acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) Propanoate) | C19H19I2NO5 | 595.18 | |
| Lafutidine | 118288-08-7 | C22H29N3O4S | 431.56 |
| Lafutidine Impurity A | C6H5NO3 | 139.11 | |
| Lafutidine Impurity B | C22H29N3O5S | 447.56 | |
| Lafutidine Impurity C | C15H23N3O | 261.37 | |
| Lafutidine Impurity D | C22H31N3O5S | 449.57 | |
| Lafutidine-d10 | C22H19N3O4SD10 | 441.62 | |
| Lafutidine Dihydro Impurity | N/A | C22H31N3O4S | 433.57 |
| Labetalol | 36894-69-6 | C19H24N2O3 | 328.41 |
| Labetalol Impurity A | N/A | C19H23NO4 | 329.4 |
| Labetalol Impurity B | N/A | C19H25NO4 | 343.43 |
| Labetalol-d6 | C19H18N2O3D6 | 334.45 | |
| Labetalol-d5 HCl | C19H19N2O3D5. HCl | 333.44 36.46 | |
| Labetalol Impurity C | 30566-92-8 | C23H22N2O3 | 374.44 |
| Labetalol Impurity D | C19H30N2O3 | 334.46 | |
| Lobucavir | C11H15N5O3 | 265.27 | |
| R-Lipoic Acid Impurity 2 (S-Oxide) | 188783-96-2 | C8H14O3S2 | 222.33 |
| rac-Lipoic Acid-d5 | C8H9O2S2D5 | 211.36 | |
| 1,2,3-Trithiane-4-Pentanoic Acid (Thioctic Acid Impurity A) | 1204245-29-3 | C8H14O2S3 | 238.39 |
| Lipoic Acid Related Compound | 916746-61-7 | C12H23NO4S2 | 309.45 |
| Dihydrolipoic Acid | 462-20-4 | C8H16O2S2 | 208.34 |
| rac-Lipoic Acid Impurity 1 (S-Oxide) | 108015-78-7 | C8H14O3S2 | 222.33 |
| rac-Lipoic Acid Impurity 2 (S-Oxide) | 6992-30-9 | C8H14O3S2 | 222.33 |
| rac-Lipoic Acid Impurity 3 (S-Oxide) | 17370-41-1 | C8H14O4S2 | 238.33 |
| R-Lipoic Acid Impurity 1 (S-Oxide) | 188745-24-6 | C8H14O3S2 | 222.33 |
| Levocarnitine Impurity B | C10H16O4 | 200.24 | |
| Levocarnitine Impurity C | C7H17N2O2 . Cl | 161.23 35.45 | |
| Levocarnitine Impurity D | C7H15N2O | 143.21 | |
| Lipstatin | 96829-59-3 | C29H49NO5 | 491.72 |
| Lipstatin-d3 | C29H46NO5D3 | 494.74 | |
| Linoleoyl Carnitine | 36816-10-1 | C25H49NO4 | 427.67 |
| Loxoprofen | 68767-14-6 | C15H18O3 | 246.31 |
| Loxoprofen Ring-opening Impurity | 1091621-61-2 | C15H18O5 | 278.31 |
| Loxoprofen related compound 1 | C25H36O3 | 384.56 | |
| Loxoprofen related compound 2 | C15H18O4 | 262.31 | |
| Levamisole Phosphate | 32093-35-9 | C11H12N2S. H3O4P | 204.30 98.00 |
| Linolenic Acid | 463-40-1 | C18H30O2 | 278.44 |
| Lycoramine | 21133-52-8 | C17H23NO3 | 289.38 |
| Mefenamic acid-d4 | 61-68-7 | C15H11D4NO2 | 245.32 |
| Mefenamic Acid Impurity D (Benzoic Acid) | 65-85-0 | C7H6O2 | 122.12 |
| Mefenamic acid-acyl-â-D-glucuronide | 102623-18-7 | C21H23NO8 | 417.42 |
| Mefenamic acid-d3 | C15H12NO2D3 | 244.31 | |
| 4-hydroxy Mefenamic acid-d3 | C15H12NO3D3 | 260.31 | |
| Mefenamic Acid | 61-68-7 | C15H15NO2 | 241.29 |
| Mefenamic Acid Impurity B | C23H24N2O | 344.46 | |
| Mefenamic Acid Impurity E | 08-11-4869 | C14H15N | 197.28 |
| Mefenamic Acid Impurity A | N/A | C8H11N | 121.18 |
| Mefenamic Acid Impurity C | N/A | C7H5ClO2 | 156.57 |
| Meloxicam | 71125-38-7 | C14H13N3O4S2 | 351.41 |
| Meloxicam Impurity (CDBC98SE) | 632-25-7 | C7H6O5S | 202.19 |
| Meloxicam Impurity (CDBC96SE) | C8H9NO4S | 215.23 | |
| Meloxicam Impurity C | C15H15N3O4S2 | 365.43 | |
| Meloxicam Impurity E | C11H11NO5S | 269.28 | |
| Meloxicam-d3 | 71125-38-7 | C14H10D3N3O4S2 | 354.42 |
| 5'-Carboxy Meloxicam | NULL | C14H11N3O6S2 | 381.39 |
| 5'-Hydroxy Meloxicam | NULL | C14H13N3O5S2 | 367.4 |
| Meloxicam Related Compound A | NA | C12H13NO5S | 283.31 |
| Meloxicam Related Compound B | NA | C4H6N2O | 98.11 |
| Meloxicam EP Impurity F (Meloxicam USP Related Compound C) | 118854-48-1 | C13H15NO5S | 297.33 |
| Meloxicam Related Compound D | NA | C15H15N3O4S2 | 365.43 |
| Meloxicam Impurity D | C16H17N3O4S2 | 379.46 | |
| Meperidine-d4 | 53484-73-4 | C15H17D4NO2 | 251.3 |
| 4-Hydroxy mephenytoin | 61837-65-8 | C12H11D3N2O3 | 234.26 |
| 4-Hydroxy Mephenytoin-d3 | 61837-65-8(non-d) | C12H11D3N2O3 | 237.28 |
| N-Desmethyl Mephenytoin-d5 | C11H7D5N2O2 | 209.26 | |
| (S)-4-Hydroxy Mephenytoin | C12H14N2O3 | 234.26 | |
| (S)-(+)-Mephenytoin | 70989-04-7 | C12H14N2O2 | 218.26 |
| Metaxalone | 1665-48-1 | C12H15NO3 | 221.26 |
| Metaxalone-d6 | 1665-48-1(non-d) | C12H9D6NO3 | 227.29 |
| Metaxalone Impurity A (3-(3, 5-Dimethylphenoxyl)-Propane-1, 2-Diol) | 59365-66-1 | C11H16O3 | 196.25 |
| Metaxalone Related Compound A | C12H16N2O2 | 220.27 | |
| Methoxsalen-d3 | 298-81-7 | C12H5D3O4 | 217.24 |
| Methoxsalen | 298-81-7 | C12H8O4 | 216.2 |
| alpha-Hydroxy Metoprolol | 56392-16-6 | C15H25NO4 | 283.37 |
| Metoprolol Impurity B | C9H12O2 | 152.19 | |
| Metoprolol Impurity F | C11H17NO2 | 195.26 | |
| Metoprolol Impurity H | C14H23NO3 | 253.34 | |
| Metoprolol Impurity I | 933468-54-3 | C14H21NO2 | 235.33 |
| Metoprolol Hemitartrate | 56392-17-7 | C15H25NO3. 0.5 C4H6O6 | 267.37 0.5 150.09 |
| (S)-(-)-Metoprolol | 81024-42-2 | C15H25NO3 | 267.37 |
| (R)-(+)-Metoprolol | 81024-43-3 | C15H25NO3 | 267.37 |
| Metoprolol-d6 Tartrate | C15H19NO3D6.0.5C4H6O6 | 273.41 75.05 | |
| Metoprolol Impurity J | C18H31NO5 | 341.45 | |
| Metoprolol Impurity A | C14H23NO3 | 253.34 | |
| Maprotiline HCl | 10347-81-6 | C20H23N. HCl | 277.41 36.46 |
| Maprotiline-d3 HCl | 1329496-63-0 | C20H20ND3. HCl | 280.43 36.46 |
| N-Desmethyl Maprotiline HCl | 92202-51-2 | C19H21N. HCl | 263.39 36.46 |
| Maprotiline Impurity E (N-Methyl Maprotiline) | 23941-38-0 | C21H25N | 291.44 |
| Metoprolol Impurity E | C15H25NO3 | 267.37 | |
| Macamide Impurity 1 | C23H39NO | 345.57 | |
| Macamide Impurity 2 | C25H41NO | 371.61 | |
| Macamide Impurity 3 | C25H39NO | 369.6 | |
| Macamide Impurity 5 | C24H41NO2 | 375.6 | |
| Macamide Impurity 9 | C26H43NO2 | 401.64 | |
| Macamide Impurity 10 | C26H41NO2 | 399.62 | |
| Metoprolol Impurity D | C12H18O4 | C12H18O4 | |
| Mitoxantrone Impurity B | C22H28N4O5 | 428.49 | |
| Mitoxantrone Impurity C | C22H27ClN4O6 | 478.94 | |
| Mitoxantrone Impurity A | 89991-52-6 | C18H19N3O5 | 357.37 |
| Mitoxantrone Impurity D | 137132-70-8 | C22H26N4O6 | 442.48 |
| Metoprolol Impurity C | C12H18ClNO3 | 259.73 | |
| N-Desmethyl mianserin | 57257-81-5 | C17H18N2 | 250.35 |
| Mitotane-d4 | C14H6Cl4D4 | 324.07 | |
| Mitotane | 53-19-0 | C14H10Cl4 | 320.05 |
| 8-Hydroxy mianserin | 102335-57-9 | C17H18N2 | 280.37 |
| Methicillin Sodium | 132-92-3 | C17H19N2O6S Na | 379.41 22.99 |
| Mianserin-d3 HCl | C18H17N2D3.HCl | 267.39 36.46 | |
| Minodronic Acid | 155648-60-5 | C9H12N2O7P2 | 322.15 |
| Minodronic Acid-d4 | N/A | C9H8N2O7P2D4 | 326.18 |
| Minodronic Acid Related Compound | 21755-34-0 | C11H12N2O2 | 204.23 |
| Mianserin HCl | C18H20N2 . HCl | 264.37 36.46 | |
| Menthol-d4 | N/A | C10H16OD4 | 160.29 |
| 2-(4,6-Diamino-1,3,5-triazin-2-yl)sulfanylethanesulfonic Acid | C5H9N5O3S2 | 251.29 | |
| 2-[[(Guanidino)(imino)methyl]sulfanyl]ethanesulfonic Acid | C4H10N4O3S2 | 226.28 | |
| 2-(2-Sulfoethyl)pseudourea | 25985-57-3 | C3H8N2O3S2 | 184.24 |
| 3-Hydroxy Mepivacaine | 37055-90-6 | C15H22N2O2 | 262.35 |
| Mepivacaine Impurity D | C15H20N2O | 244.34 | |
| Mepivacaine Impurity E | C15H21ClN2O | 280.8 | |
| Melperone-d4 HCl | 1622-79-3 (non-labelled) | C16H18FNOD4. HCl | 267.38 36.46 |
| Melperone HCl | 1622-79-3 | C16H22FNO. HCl | 263.36 36.46 |
| MTSL (S-(2,2,5,5-Tetramethyl-2,5-Dihydro-1H-Pyrrol-3yl)methyl Methanesulfonothioate | 81213-52-7 | C10H18NO3S2 | 264.39 |
| Methiocarb sulfoxide-d3 | C11H12NO3SD3 | 244.33 | |
| Mirtazapine-d4 HCl | 61337-67-5 (non-d) | C17H15D4N3.HCl | 305.82 |
| Mirtazapine Impurity C | N/A | C17H17N3O | 279.34 |
| Moroxydine Hydrochloride | 3160-91-6 | C6H13N5O . HCl | 171.20 36.46 |
| Mirtazapine Impurity F (10-oxo mirtazapine) | 191546-97-1 | C17H17N3O | 279.34 |
| Mirtazapine | 85650-52-8 | C17H19N3 | 265.36 |
| Mirtazapine Carbonitrile Impurity | 61337-88-0 | C17H18N4 | 278.36 |
| Mirtazapine N-Glucuronide | N/A | C23H27N3O6 | 441.49 |
| Mirtazapine Impurity A (Desmethyl mirtazapine HCl) | C16H17N3.HCl | 287.79 | |
| Meclozine | 569-65-3 | C25H27ClN2 | 390.96 |
| Meclozine EP Impurity B (4-Chlorobenzhydrol) | 119-56-2 | C13H11ClO | 218.69 |
| Desmethyl mirtazapine-d4 HCl | NULL | C16H13D4N3.HCl | 291.79 |
| Moclobemide | 71320-77-9 | C13H17ClN2O2 | 268.75 |
| Moclobemide-N-Oxide | C13H17ClN2O3 | 284.75 | |
| Molclobemide-d4 | C13H13ClN2O2D4 | 272.77 | |
| Moclobemide morpholine C-oxidized derivative | C13H15ClN2O2 | 266.73 | |
| 8-Hydroxy mirtazapine | 102335-57-9 | C17H19N3O | 281.36 |
| Myristamidopropyl Dimethylamine | 45267-19-4 | C19H40N2O | 312.54 |
| 8-Hydroxy mirtazapine-d4 | 102335-57-9(non-d) | C17H15D4N3O | 285.38 |
| Methacrylic Acid | 79-41-4 | C4H6O2 | 86.09 |
| Mirtazapine-13C-d3 HCl | C1613CH16N3D3.HCl | 269.37 36.46 | |
| Meptazinol | 54340-58-8 | C15H23NO | 233.36 |
| Meptazinol Hydrochloride | 59263-76-2 | C15H23NO.HCl | 233.36 36.5 |
| Meptazinol-13CD3 | C15H20NOD3 | 237.36 | |
| Meptazinol impurity A | C15H21NO2 | 247.34 | |
| Meptazinol impurity B | C15H23N | 217.36 | |
| Meptazinol impurity C | C30H44N2O | 448.7 | |
| Meptazinol impurity D | C30H44N2O | 448.7 | |
| Meptazinol impurity E | C19H31NO | 289.47 | |
| Mirtazapine-d4 | 85650-52-8 (non-labelled) | C17H15D4N3 | 269.39 |
| Miglustat | 72599-27-0 | C10H21NO4 | 219.28 |
| Miglustat-D9 | C10H12NO4D9 | 228.34 | |
| Mirtazapine Impurity E | C17H21N3 | 267.38 | |
| Miriplatin Impurity | N/A | C34H68N2O6Pt2 | 991.11 |
| Mirtazapine Impurity B | N/A | C17H19N3O H2O | 281.36 18.02 |
| N-Ethyl-beta-Methylphenethylamine | 91339-15-0 | C11H17N | 163.26 |
| N, N-Dimethyl-beta-Methylphenethylamine | 7560-81-8 | C11H17N | 163.26 |
| N-Methyl-beta-Methylphenethylamine | 93-88-9 | C10H15N | 149.24 |
| Myricetin | 529-44-2 | C15H10O8 | 318.24 |
| Myricetin impurity 1 | C15H10O7 | 302.24 | |
| Midodrine-d6 HCl | 3092-17-9 (non-d) | C12H12D6N2O4.HCl | 296.78 |
| Bis(2-Ethylhexyl)-Maleate | 142-16-5 | C20H36O4 | 340.51 |
| Midodrine Related Compound A (Desglymidodrine) | 3600-87-1 | C10H15NO3 | 197.24 |
| delta-D-Mannonolactone | 32746-79-5 | C6H10O6 | 178.14 |
| Maxacalcitol | 103909-75-7 | C26H42O4 | 418.62 |
| Maxacalcitol 9-Hydroxy Iso Form | C26H42O4 | 418.62 | |
| Maxacalcitol Impurity B | 132071-85-3 | C26H42O4 | 418.62 |
| Maxacalcitol Preform | C26H42O4 | 418.62 | |
| Methomyl | 16752-77-5 | C5H10N2O2S | 162.21 |
| Mexiletine-D6 Hydrochloride | C11H11NOD6.HCl | 185.30 36.46 | |
| Maytansine | 35845-53-8 | C34H46ClN3O10 | 692.21 |
| Maytansinoid DM4 | C38H54ClN3O10S | 780.39 | |
| Megastigmatrienone (Tabanone) | 13215-88-8 | C13H18O | 190.29 |
| Mepartricin | 11121-32-7 | C59H86N2O19 | 1127.35 |
| S(OH), R-Metconazole ((-)-cis-5-[(4-chlorophenyl)methyl]-2,2-dimethyl-1-(1H-1,2,4-triazole-1-ylmethyl]cyclopentanol) | C17H22ClN3O | 319.84 | |
| R(OH), S-Metconazole ((1R,5S)-5-[(4-chlorophenyl)methyl]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol) | C17H22ClN3O | 319.84 | |
| Minoxidil-d10 | 38304-91-5 (non-labelled) | C9H5D10N5O | 219.31 |
| Minoxidil-d10 sulfate | 83701-22-8(non-d) | C9H5D10N5O4S | 299.37 |
| Minoxidil glucuronide | 56828-40-1 | C15H23N5O7 | 385.38 |
| Minoxidil Sulphate | C9H15N5O.H2O4S | 209.25 98.08 | |
| Desoxyminoxidil | 24867-26-3 | C8H13N5 | 179.23 |
| Minoxidil Impurity A | C4H5ClN4O | 160.56 | |
| Minoxidil Impurity B | C4H5ClN4 | 144.56 | |
| Minoxidil Impurity C | C9H14N4O | 194.24 | |
| Minoxidil Impurity D | 75105-16-7 | C11H12N4O4S | 296.31 |
| Mometasone furoate-d3 | 83919-23-7 | C27H27D3Cl2O6 | 524.46 |
| Mometasone Furoate Impurity E | N/A | C32H32Cl2O8 | 615.51 |
| Mometasone Furoate Impurity F | 1305334-30-8 | C27H28Cl2O7 | 535.43 |
| Mometasone Furoate Impurity I | N/A | C29H34Cl2O8 | 581.5 |
| Mometasone-d6 | C22H22Cl2O4D6 | 433.41 | |
| Mometasone-17, 20-Difuroate | N/A | C32H32Cl2O8 | 615.51 |
| Mometasone Furoate Impurity 1 | C26H29ClO7 | 488.97 | |
| Mometasone (Mometasone Furoate Impurity G) | 105102-22-5 | C22H28Cl2O4 | 427.37 |
| Mometasone Furoate | C27H30Cl2O6 | 521.44 | |
| Mometasone Furoate Impurity C | N/A | C27H29ClO6 | 484.98 |
| Mometasone Furoate Impurity D | 83881-09-8 | C27H29ClO6 | 484.98 |
| Mometasone Furoate Impurity H | N/A | C27H31ClO7 | 503 |
| Mometasone Furoate Impurity A | 83880-65-3 | C27H29ClO5 | 468.98 |
| Mometasone Furoate Impurity B | N/A | C28H31ClO8S | 563.07 |
| Methotrimeprazine-d3 | NULL | C19H21N2OSD3 | 331.5 |
| Methotrimeprazine Sulfoxide | NULL | C19H24N2O2S | 344.48 |
| Mycophenolic Acid Phenyl Glucuronide | C23H28O12 | 496.47 | |
| Mycophenolic Acid-13C-d3 | N/A | C17H17O6D3 | 324.35 |
| (4Z)-Mycophenolate mofetil | C23H31NO7 | 433.51 | |
| Mycophenolate Impurity B | C29H42N2O9 | 562.67 | |
| Mycophenolate Impurity D | C24H33NO7 | 447.53 | |
| Mycophenolic Acid-d3-Beta-D-Glucuronide | 31528-44-6 (non-labelled) | C23H25O12D3 | 499.49 |
| Mycophenolic Acid Cyclopropane Analogue | 125198-40-5 | C18H22O6 | 334.37 |
| Dihydroxy Analogue of Mycophenolic Acid | 31858-65-8 | C16H18O6 | 306.32 |
| Dimethoxy Analogue of Mycophenolic Acid | C18H22O6 | 334.37 | |
| Vinyl Lactone Analogue of Mycophenolic Acid | C17H18O6 | 318.33 | |
| Mycophenolate Mofetil Impurity A, O-Desmethyl impurity | 1322681-36-6 | C22H29O7 | 419.48 |
| Mycophenolic acid glucuronide cyclopropane analogue | NULL | C24H30O12 | 510.5 |
| Mycophenolic acid acyl glucoside | 344562-78-3 | C23H30O11 | 482.49 |
| Mycophenolate Mofetil Impurity E | 31858-66-9 | C18H22O6 | 334.37 |
| Mycophenolic Acid Related Compound 1 (5,7-Dihydroxy-4 methylphthhalide) | C9H8O4 | 180.16 | |
| Mycophenolic acid | 24280-93-1 | C17H20O6 | 320.35 |
| Mycophenolic acid-d3 | 24280-93-1 | C17H17O6D3 | 323.36 |
| Mycophenolate mofetil | 115007-34-6 | C23H31NO7 | 433.51 |
| Mycophenolate mofetil-d4 | 115007-34-6 (non-d) | C23H27D4NO7 | 437.51 |
| Mycophenolic acid acyl glucuronide | C23H28O12 | 496.47 | |
| Mycophenolic Acid Phenolic beta-D-Glucoside | 55533-52-3 | C23H30O11 | 482.49 |
| Mycophenolate Sodium | C17H19O6. Na | 319.34 22.99 | |
| N-Acetyl Mesalamine | 51-59-2 | C9H9NO4 | 195.18 |
| Mesalamine Impurity | C8H7NO5 | 197.15 | |
| Mesalamine Impurity J | 112725-89-0(non-HCl) | C7H8N2O3 . HCl | 168.15 36.46 |
| 2-Hydroxy-5-amino-N-(2-carboxy-4-aminophenyl)benzoic Acid | N/A | C14H12N2O5 | 288.26 |
| Mesalamine Impurity C | 95-55-6 | C6H7NO | 109.13 |
| Mesalamine Impurity F | 570-23-0 | C7H7NO3 | 153.14 |
| Mesalamine Impurity G | 490-79-9 | C7H6O4 | 154.12 |
| Mesalamine Impurity H | 69-72-7 | C7H6O3 | 138.12 |
| Mesalamine Impurity L | 118-91-2 | C7H5ClO2 | 156.57 |
| Mesalamine Impurity M | 2516-96-3 | C7H4ClNO4 | 201.57 |
| Mesalamine Impurity P | N/A | C13H11NO6S | 309.3 |
| N-Acetyl Mesalamine-d3 | 1309935-89-4 | C9H6NO4D3 | 198.19 |
| Mesalamine | 89-57-6 | C7H7NO3 | 153.14 |
| N-Formyl-5-aminosalicylic Acid | C8H7NO4 | 181.15 | |
| Mesalamine Related Compound (N-Butyryl-5-Aminosalicylic Acid) | 93968-81-1 | C11H13NO4 | 223.23 |
| N-D-Glucopyranosyl-5-aminosalicylic Acid | C13H17NO8 | 315.28 | |
| N-Propionyl Mesalazine-d3 | C10H8NO4D3 | 212.22 | |
| Mesalamine Impurity I | 13147-53-3 | C13H10N2O3 | 242.24 |
| 3,6-Dioxocyclohexa-1,4-diene-1-carboxylic Acid | C7H4O4 | 152.11 | |
| 5-Amino-2-((5-amino-2-hydroxybenzoyl)amino)benzoic Acid | C14H12N2O5 | 288.26 | |
| 5-Amino-2-((5-amino-2-hydroxybenzoyl)oxy)benzoic Acid | C14H12N2O5 | 288.26 | |
| Mesalamine-d3 | 1309283-32-6 | C7H4NO3D3 | 156.16 |
| N-Propionyl mesalamine | C10H11NO4 | 209.2 | |
| N-Acetyl -4-aminosalicyclic Aci | C9H9NO4 | 195.18 | |
| N-Acetyl-d3 Mesalamine | C9H6NO4D3 | 198.19 | |
| 5-(N-β-D-Glucopyranosylamino)acetylsalicylic acid | C15H19NO9 | 357.32 | |
| Mesalamine Impurity | C8H7NO5 | 197.15 | |
| Mesalamine-13C6 HCl | C7H7NO3 . HCl | 159.07 36.46 | |
| Mupirocin Lithium | 73346-79-9 | C26H43O9.Li | 506.57 |
| Mecoprop-d3 | 352431-15-3 | C10H8ClO3D3 | 217.67 |
| Metolachlor-d6 | 51218-45-2 | C15H16ClNO2D6 | 289.83 |
| Misoprostol acid | NULL | C21H36O5 | 368.52 |
| Misoprostol acid-d5 | NULL | C21H31D5O5 | 373.52 |
| 8-epi-Misoprostol | N/A | C22H38O5 | 382.55 |
| Misoprostol Impurity (A-Form) | N/A | C22H36O4 | 364.53 |
| Misoprostol Impurity (B-Form) | N/A | C22H36O4 | 364.54 |
| Misoprostol | C22H38O5 | 382.55 | |
| R-Manidipine | NULL | C35H38N4O6 | 610.72 |
| Manidipine DiHCl | 89226-75-5 | C35H38N4O6 . 2 HCl | 610.72 2 36.46 |
| R-Manidipine-d4 | NULL | C35H34N4O6D4 | 614.74 |
| S-Manidipine | NULL | C35H38N4O6 | 610.72 |
| S-Manidipine-d4 | NULL | C35H34N4O6D4 | 614.74 |
| Manidipine | C35H38N4O6 | 610.72 | |
| Manidipine-d4 | C35H34N4O6D4 | 614.74 | |
| Manidipine Benzylidene | 119128-13-1 | C12H11NO5 | 249.23 |
| Manidipine Bis Analog | N/A | C53H58N6O6 | 875.09 |
| Manidipine Crotonate DiHCl | N/A | C24H30N2O2. 2 HCl | 378.52 2 36.46 |
| Moxifloxacin | 151096-09-2 | C21H24FN3O4 | 401.44 |
| Moxifloxacin Impurity E (8-Hydroxy Moxifloxacin) | N/A | C20H22FN3O4 | 387.41 |
| 8-Ethoxy Moxifloxacin HCl | C22H26FN3O4 . HCl | 415.47 36.46 | |
| 6-Methoxy Moxifloxacin | C21H25N3O4 | 383.45 | |
| Moxifloxacin Impurity | 172426-88-9 | C14H13N2O4 | 292.27 |
| 8-Desmethoxy-8-Fluoro Moxifloxacin | C20H21F2N3O3 | 389.41 | |
| Moxifloxacin-R-isomer (ent-Moxifloxacin) | 268545-13-7 | C21H24FN3O4 | 401.44 |
| Moxifloxacin Impurity | N/A | C22H26FN3O4 | 415.47 |
| N-Methyl Moxifloxacin HCl | 354812-41-2 | C22H26FN3O4 HCl | 415.47 36.46 |
| Mexifloxacin Boron Complex Impurity | N/A | C18H17BF2NO8 | 424.15 |
| Moxifloxacin Impurity | C16H16FNO5 | 321.31 | |
| Moxifloxacin-d4 HCl | 151096-09-2 (non-d) | C21H20FN3O4D4.HCl | 405.47 36.46 |
| Moxifloxacin Related Compound (1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid) | 112811-72-0 | C14H11F2NO4 | 295.24 |
| 8-Methoxy Quinolonic Ethyl Ester | C16H15F2NO4 | 323.3 | |
| Moxifloxacin acyl sulfate | NULL | C21H24FN3O7S | 481.5 |
| Moxifloxacin N-sulfate | NULL | C21H24FN3O7S | 481.5 |
| Moxifloxacin acyl glucuronide | C27H32FN3O10 | 577.57 | |
| 6,8-Dimethoxy Moxifloxacin | C22H27N3O5 | 413.48 | |
| 8-Fluoro-6-Methoxy Moxifloxacin | C21H24FN3O4 | 401.44 | |
| Moxifloxacin Hydroxy Quinoline Impurity | N/A | C13H9F2NO4 | 281.22 |
| Bromomethlenediphosphonic Acid | 10596-21-1 | CH3BrO6P2 | 252.88 |
| Difluoromethlenediphosphonic Acid | 10596-32-4 | CH2F2O6P2 | 209.97 |
| Mifepristone | 84371-65-3 | C29H35NO2 | 429.61 |
| Mifepristone-D6 | C29H29NO2D6 | 435.64 | |
| N-Demethyl Mifepristone-D3 | C28H30NO2D3 | 418.6 | |
| Mifepristone-d3 | 84371-65-3 (non-d) | C29H32NO2D3 | 432.63 |
| N-Desmethyl Mifepristone | 104004-96-8 | C28H33NO2 | 415.58 |
| N-Didesmethyl Mifepristone | 104004-92-4 | C27H31NO2 | 401.55 |
| Hydroxy Mifepristone | 105012-15-5 | C29H35NO3 | 445.61 |
| Hydroxy Mifepristone-d6 | C29H29NO3D6 | 451.64 | |
| Mifepristone related compound | 84371-64-2 | C31H41NO4 | 491.68 |
| 11-ent-Mifepristone | C29H35NO2 | 429.61 | |
| N, N-Didesmethyl Mifepristone-D4 | C27H27NO2D4 | 405.58 | |
| Montelukast sodium | 151767-02-1 | C35H35ClNO3S.Na | 585.19 22.99 |
| Montelukast R, S-Isomer | N/A | C41H46ClNO5S2 | 732.41 |
| cis-Montelukast | 774538-96-4 | C35H36ClNO3S | 586.2 |
| Montelukast Impurity I | C35H36ClNO4S | 602.2 | |
| Montelukast Impurity H | 851755-56-1 | C34H32ClNO4S | 586.16 |
| Montelukast Keto Carbinol Impurity | N/A | C34H32ClNO4S | 586.16 |
| Montelukast S-Enantiomer Sodium Salt | C35H35ClNO3S.Na | 585.19 22.99 | |
| Montelukast Methyl Ether | C36H38ClNO3S | 600.23 | |
| Montelukast Sulfone | C35H36ClNO5S | 618.2 | |
| Montelukast Dihydro Impurity | 142147-98-6 | C35H38ClNO3S | 588.22 |
| Montelukast Cyclopropacetaneamide Impurity | 866923-63-9 | C35H37ClN2O2S | 585.21 |
| Montelukast-d6 sodium | 151767-02-1 (non-d) | C35H29ClNO3SD6.Na | 591.25 22.99 |
| Montelukast 1, 2-Diol | 186352-97-6 | C35H36ClNO4S | 602.2 |
| Montelukast CN Impurity | N/A | C35H35ClN2OS | 567.2 |
| Montelukust Keto Impurity | N/A | C28H24ClNO2 | 441.96 |
| Montelukust Diol Impurity | N/A | C29H28ClNO2 | 458.01 |
| Montelukast Sulfone N-Oxide | N/A | C35H35ClNO6S | 633.19 |
| Montelukast sulfoxide sodium | NULL | C35H35ClNO4S.Na | 601.19 22.99 |
| Montelukast-acyl-β-D-glucuronide | C42H46ClNO8S | 760.35 | |
| Montelukast-d6 | C35H30ClNO3SD6 | 592.24 | |
| Montelukast Methyl Ketone (Mok-3 Keto) | 937275-23-5 | C34H32ClNO3S | 570.16 |
| Montelukast Sulfoxide (Mixtuture of Diastereomers) | C35H36ClNO4S | 602.2 | |
| Montelukast Methylstyrene Impurity | 918972-54-0 | C35H34ClNO2S | 568.18 |
| Montelukast R, R-Isomer | N/A | C41H46ClNO5S2 | 732.41 |
| Moexipril | 103775-10-6 | C27H34N2O7 | 498.58 |
| Moexipril-d5 | 103775-10-6 (non-d) | C27H29N2O7D5 | 503.61 |
| Moexiprilat-d5 | NULL | C25H25N2O7D5 | 475.56 |
| Moexiprilat | NULL | C25H30N2O7 | 470.53 |
| Moexipril Acyl Glucuronide | NULL | C31H38N2O13 | 646.65 |
| Mirodenafil | 862189-95-5 | C26H37N5O5S | 531.68 |
| Mirodenafil-d7 | N/A | C26H30N5O5SD7 | 538.72 |
| Modafinil | 68693-11-8 | C15H15NO2S | 273.36 |
| Modafinil-d5 | 68693-11-8 (non-d) | C15H10NO2SD5 | 278.39 |
| Modafinil acid | 63547-24-0 | C15H14O3S | 274.34 |
| (R)-Modanifil acid | 112111-45-2 | C15H14O3S | 274.34 |
| S-Modafinil | C15H15NO2S | 273.36 | |
| R-Modafinil | C15H15NO2S | 273.36 | |
| Modafinil Sulfone | 118779-53-6 | C15H15NO3S | 289.36 |
| Modafinil-d5 Acid | C15H9O3SD5 | 279.37 | |
| (R)-(-)-Modafinil-d5 Acid | C15H9O3SD5 | 279.37 | |
| (S)-(+)-Modafinil-d5 Acid | C15H9O3SD5 | 279.37 | |
| Minocycline-D6 | 10118-90-8 (non-d) | C23H21N3O7D6 | 463.52 |
| (R)-(-)-Modafinil-d5 | C15H10NO2SD5 | 278.39 | |
| (S)-(+)-Modafinil-d5 | C15H10NO2SD5 | 278.39 | |
| (S)-(+)-Modafinil Acid | C15H16O3S | 274.34 | |
| Modafinil-d5 Sulfone | C15H10NO3SD5 | 294.39 | |
| Modafinil Acid Sulfone | C15H14O4S | 290.34 | |
| Modafinil-d5 Acid Sulfone | C15H9O4SD5 | 295.37 | |
| Modafinil Impurity A | C15H15NO3S | 289.36 | |
| 2-[( Diphenyl methyl)sulfinyl] acetic acid methyl ester | C16H16O3S | 288.37 | |
| 7-Ethylmethylamino Analogue | C24H29N3O7 | 471.51 | |
| Minocycline impurity A (4-epi Minocycline) | C23H27N3O7 | 457.49 | |
| Minocycline-13C-d3 | 10118-90-8 (non-d) | C23H24N3O7D3 | 461.49 |
| Minocycline HCl | C23H27N3O7. HCl | 457.49 36.46 | |
| Minocycline Dehydro Analogue | C23H25N3O7 | 455.47 | |
| Imino Delta Minocycline | C23H28N4O6 | 456.5 | |
| Minocycline Impurity B (Sancycline) | 808-26-4 | C21H22N2O7 | 414.42 |
| Minocycline Impurity C (7-Monodemthylminocycline) | C22H25N3O7 | 443.46 | |
| Minocycline Impurity D (7-Aminosancycline) | C21H23N3O7 | 429.43 | |
| 6-Methoxy-2-naphthylacetic acid (6-MNA) | C13H12O3 | 216.24 | |
| 6-Methoxy-2-naphthylacetic acid (6-MNA)-13C-d3 | C13H9O3D3 | 220.25 | |
| 6-Methoxy-2-naphthylacetic acid (6-MNA) sulfate | C13H12O6S | 296.3 | |
| 6-Methoxy-2-naphthylacetic acid (6-MNA) glucuronide | C19H20O9 | 392.37 | |
| Metopimazine | 14008-44-7 | C22H27N3O3S2 | 445.61 |
| Metopimazine-d6 | 14008-44-7 (non-d) | C22H21N3O3S2D6 | 451.64 |
| Metopimazine acid | C22H26N2O4S2 | 446.59 | |
| Metopimazine acid-d6 | C22H20N2O4S2D6 | 452.63 | |
| Metopimazine Sulfoxide | 18181-99-2 | C22H27N3O4S2 | 461.61 |
| 6-Desmethyl Moxonidine (Moxonidine Impurity D) | C8H10ClN5O | 227.65 | |
| Moxonidine | 75438-57-2 | C9H12ClN5O | 241.6 |
| Moxonidine-d3 | 75438-57-2 (non-d) | C9H9ClN5OD3 | 244.72 |
| Moxonidine-d4 | C9H8ClN5OD4 | 245.71 | |
| Moxonidine Impurity B | 75439-01-9 | C10H15N5O2 | 237.26 |
| Moxonidine Impurity C (4-Hydroxymoxonidine) | C9H13N5O2 | 223.24 | |
| Memantine HCl | C12H21N.HCl | 179.31 36.46 | |
| Memantine Impurity C | 19982-07-1 | C14H23NO | 221.35 |
| 1,2-Dimethyl Adamantane | 16207-81-1 | C12H20 | 164.29 |
| 1,4-Dimethyl Adamantane | N/A | C12H20 | 164.29 |
| 1-Amino-3, 5, 7-Trimethyl-Adamantane HCl | 15210-60-3 | C13H23N HCl | 193.33 36.46 |
| 1,3,5-Trimethyl Adamantane | 707-35-7 | C13H22 | 178.32 |
| 1-Hydroxy-3,5-dimethyladamantane | |||
| Memantine Impurity (1-Amino-3-Ethyl Adamantine) | 80121-67-1 | C12H21N HCl | 179.31 36.46 |
| Memantine-d6 HCl | 1189713-18-5 | C12H15ND6.HCl | 221.8 |
| 3-Methyl-1-aminoadamantane HCl | 33103-93-4 | C11H20ClN | 201.74 |
| Memantine Impurity IV (1-Amino-3-Hydroxy-5,7-Dimethyladamantane) | 63971-25-5 | C12H21NO | 195.31 |
| Memantine-d3 HCl | C12H18ND3.HCl | 182.33 36.46 | |
| 1-Chloro-3,5-dimethyladamantane | 707-36-8 | C12H19Cl | 198.74 |
| 1,3-Dimethyladamantane | 702-79-4 | C12H20 | 164.29 |
| Memantine Impurity B | 941-37-7 | C12H19Br | 243.19 |
| MPP-d3 Iodide (1-methyl-4-phenylpyridinium-d3 iodide) | C12H9ND3.I | 173.25 126.90 | |
| Meclizine DiHCl | 1104-22-9 | C25H27ClN2.2 HCl | 390.96 2 36.46 |
| Meclizine-d8 | 569-65-3 (non-d) | C25H19ClN2D8 | 398.99 |
| Meclizine N-Oxide (N4-oxide) | C25H27ClN2O | 406.96 | |
| Meclizine N-Oxide (N1-oxide) | C25H27ClN2O | 406.96 | |
| Meclizine N-Oxide (N, N'-dioxide) | C25H27ClN2O2 | 422.96 | |
| Meclizine-d8 dihydrochloride | C25H19ClN2D8.2 HCl | 399.01 2 36.46 | |
| Milnacipran Hydrochloride | 101152-94-7 | C15H22N2O.HCl | 246.36 36.46 |
| L-Milnacipran-d5 | N/A | C15H17N2OD5 | 251.39 |
| D-Milnacipran-d5 | N/A | C15H17N2OD5 | 251.39 |
| L-Milnacipran trans Isomer | C15H22N2O.HCl | 246.36 36.46 | |
| Milnacipran | 92623-85-3 | C15H22N2O | 246.36 |
| Milnacipran-d10 | 92623-85-3 (non-d) | C15H12N2OD10 | 256.42 |
| L-Milnacipran | C15H22N2O | 246.36 | |
| D-Milnacipran | C15H22N2O | 246.36 | |
| Milnacipran-d5 HCl | 101152-94-7 (non-labelled) | C15H17N2OD5.HCl | 251.39 36.46 |
| Milnacipran Carbamoyl-O-Glucuronide | N/A | C22H30N2O9 | 466.49 |
| N-Desethyl Milnacipran | 105310-07-4 | C13H18N2O | 218.3 |
| N-Desethyl Milnacipran-d5 | N/A | C13H13N2OD5 | 223.33 |
| Metformin-d6 HCl | 657-24-9 (non-d) | C4H5N5D6.HCl | 135.20 36.46 |
| Metformin Hydroxy Analog Impurity | C2H6N4O | 102.1 | |
| Metformin HCl | C4H11N5.HCl | 129.17 36.46 | |
| Metformin EP Impurity B (Monoguanyl Melamine) | 07-08-4405 | C4H8N8 | 168.16 |
| N,N-Dimethyl Melamine | C6H12N8 | 196.22 | |
| Metformin Impurity D | C3H6N6 | 126.12 | |
| Metformin Impurity C | 1985-46-2 | C5H10N6 | 154.18 |
| Metformin Impurity E (1-Methylbiguanide) Sulfate | 36801-25-9 | C3H9N5. H2O4S | 115.14 98.08 |
| Metformin Impurity F | C4H12N6 | 144.18 | |
| Methimazole-d3 | 60-56-0 (non-d) | C4H3N2SD3 | 117.19 |
| Methimazole (Thiamazole) Impurity B | 616-47-7 | C4H6N2 | 82.11 |
| Medroxyprogesterone acetate | 520-85-4 | C24H34O4 | 386.54 |
| Medroxyprogesterone Glucuronide | N/A | C28H40O9 | 520.63 |
| Medroxyprogesterone acetate impurity F (4,5-beta-Dihydromedroxyprogesterone acetate) | 69688-15-9 | C24H36O4 | 388.55 |
| Medroxyprogesterone EP Impurity C | C24H34O4 | 386.54 | |
| Medroxyprogesterone EP Impurity D | C24H34O4 | 386.54 | |
| Medroxyprogesterone EP Impurity I | C22H32O3 | 344.5 | |
| Medroxyprogesterone EP Impurity A | C24H34O5 | 402.54 | |
| Medroxyprogesterone EP Impurity F | C24H36O4 | 388.55 | |
| Medroxyprogesterone EP Impurity E | C24H32O4 | 384.52 | |
| Medroxyprogesterone EP Impurity H | C23H32O4 | 372.51 | |
| Medroxyprogesterone acetate-13C2-d3 | 520-85-4 (non-d) | C24H31O4D3 | 391.54 |
| Medroxyprogesterone acetate-d10 | 520-85-4 (non-d) | C24H24O4D10 | 396.54 |
| Medroxyprogesterone 17-Acetate-d3 | 71-58-9 (non-labelled) | C24H31O4D3 | 389.55 |
| Medroxyprogesterone (Medroxyprogesterone EP Impurity B) | 520-85-4 | C22H32O3 | 344.5 |
| Medroxyprogesterone-d3 | 162462-69-3 | C22H29O3D3 | 347.52 |
| Medroxyprogesterone-d7 | N/A | C22H25O3D7 | 351.54 |
| Medroxyprogesterone-13C-d3 | N/A | C22H29O3D3 | 348.51 |
| 1,2-Dehydro Medroxyprogesterone | 3660-13-7 | C22H30O3 | 342.48 |
| M-462 | |||
| DL-Methionine | C5H11NO2S | 149.21 | |
| Methyl 4-Acetamido-5-Bromo-2-Methoxybenzoate | C11H12BrNO4 | 302.13 | |
| Mebeverine HCl | 2753-45-9 | C25H35NO5. HCl | 429.56 36.46 |
| Desmethyl Mebeverine Alcohol-d5 | C15H20NO2D5 | 256.4 | |
| Desmethyl Mebeverine Alcohol | C15H25NO2 | 251.37 | |
| Mebeverine Alcohol-d5 | C16H22NO2D5 | 270.43 | |
| Mebeverine Alcohol HCl | C16H27NO2. HCl | 265.40 36.46 | |
| Mebeverine-d6 HCl | C25H29NO5D6.HCl | 435.60 36.46 | |
| Desmethyl Mebeverine acid | 586357-02-0 | C15H23NO3 | 265.36 |
| Desmethyl Mebeverine Acid-d5 | C15H18NO3D5 | 270.39 | |
| Mebeverine alcohol (MAL) | C16H27NO2 | 265.4 | |
| Mebeverine Acid HCl | 475203-77-1 (free base) | C16H25NO3. HCl | 279.38 36.46 |
| Desmethyl Mebeverine Acid-d6 | C15H17NO3D6 | 271.39 | |
| DMAC acyl glucuronide | C21H31NO9 | 441.48 | |
| DMAC phenolic glucuronide | C21H31NO9 | 441.48 | |
| Mitiglinide | 145375-43-5 | C19H25NO3 | 315.42 |
| Mitiglinide-d5 | 145375-43-5 (non-labelled) | C19H20NO3D5 | 320.45 |
| Mitiglinide acyl glucuronide | C25H33NO9 | 491.54 | |
| Mitiglinide calcium | 207844-01-7 | C38H48CaN2O6 . 2 H2O | 668.90 2 18.02 |
| Mitiglinide Impurity I | N/A | C19H25NO3 | 315.42 |
| (2R)-Mitiglinide Calcium Salt Monohydrate | 1266354-02-2 (anhydrous) | C19H24NO3. 0.5 Ca . H2O | 314.41 0.5 40.08 18.02 |
| Mitiglinide impurity E | C19H25NO4 | 331.42 | |
| Mitiglinide Impurity B | N/A | C11H12O4 | 208.22 |
| Mitiglinide Impurity C | C19H25NO3 | 315.42 | |
| Mildronate-d3 | 76144-81-5 (non-labelled) | C6H11N2O2D3 | 149.21 |
| Mildronate | 76144-81-5 | C6H14N2O2 | 146.19 |
| Methocarbamol | 532-03-6 | C11H15NO5 | 241.25 |
| Methocarbamol-d5 | 532-03-6(non-d) | C11H10D5NO5 | 246.28 |
| Methocarbamol glucuronide | C17H23NO11 | 417.37 | |
| Methocarbamol sulfate | C11H15NO8S | 321.31 | |
| Methocarbamol-13C-d3 | NA | C11H12NO5D3 | 245.25 |
| Metamizole Sodium Salt (Dipyrone) | 68-89-3 | C13H16N3NaO4S | 333.34 |
Comments
Post a Comment